Michael Korenfeld is an Ophthalmology physician affiliated with Comprehensive Eye Care. OpenAlex indexes 37 publications with 689 citations (h-index 14); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
901 E 3rd St
Washington, MO 630903010
Telephone
636-390-3999Provider last certified this registry record 28 Sept 2022.
Clinical trials
- Eyelash Prostheses Compared to 5.0% Lifitegrast BID for Dry Eye Disease.
Sponsor: D.E.L., LLC
- Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Sponsor: Kala Pharmaceuticals, Inc.
- Hydrophilic Acrylic Intraocular Lens
Sponsor: EyeKon Medical, Inc.
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
11 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Tarsus Pharmaceuticals, Inc.Program year20251 payment
- Thea Pharma Inc.Program year20251 payment
- ABBVIE INC.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
81.2%Prostaglandin Analog34.1%Latanoprost81%Lumigan13%Travoprost7%Part D≥130 patientsCorticosteroid26%Prednisolone Acetate97%Fluorometholone3%Part D<11 patients+ 8 more classes in this area
Cardiovascular
12.7%Beta blocker12.7%Timolol Maleate100%Part D≥58 patientsAnti-infectives
2.7%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor1.4%Valacyclovir100%Part D≥12 patientsMacrolide0.6%Erythromycin100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Ali Bijani
Babol University of Medical Sciences
Hamid Asayesh
Ayatollah Boroujerdi University
John J. Huang
Isfahan University of Medical Sciences
Fotis Topouzis
National University of Singapore
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”